NEW YORK, Sept. 17, 2026 /PRNewswire/ -- Inductive launched Beacon-2 today, a system that predicts the efficacious human dose of a small molecule directly from its chemical structure. Dose is the ...

Team to develop and validate computational models trained on data from organoids and advanced human model systems that will improve drug safety and reduce reliance on animal testing NEW YORK, Dec. 8, ...

In the complex and costly world of pharmaceutical development, the process of drug discovery remains one of the most significant bottlenecks, with scientists often describing compound optimization as ...

Inductive Bio, a company democratizing AI models to transform small molecule drug discovery, announced that it has raised $25 million in Series A funding led by Obvious Ventures with participation ...